• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

byConstance Wu
April 21, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Transcatheter aortic valve implantation is associated with reduced rate of structural valve deterioration compared to surgery

Apixaban is associated with a lower risk of gastrointestinal bleeding than other direct oral anticoagulants

Apixaban is superior to rivaroxaban in patients with atrial fibrillation and valvular heart disease

1. After successful transcatheter aortic valve replacement, compared to an anti-platelet based strategy, patients that received an anti-coagulation strategy including rivaroxaban at a dose of 10 mg daily had a higher risk of death, thromboembolic complications, and bleeding.

Evidence Rating: 1 (Excellent)

Transcatheter aortic-valve replacement (TAVR) is a treatment option for patients with severe symptomatic aortic stenosis. Currently, guidelines recommend dual antiplatelet therapy following successful TAVR to prevent thromboembolic events (TE) and complications such as stroke, MI, and DVT. Although rivaroxaban, a factor Xa inhibitor, has been shown to reduce TE events in other clinical settings, its suitability for post-TAVR anticoagulation has not been well studied. In this randomized controlled trial, 1644 patients without an absolute contraindication to anticoagulation or absolute indication for antiplatelet therapy were assigned to receive either anticoagulation (rivaroxaban 10 mg daily plus aspirin 75-100 mg daily for 3 months, followed by rivaroxaban monotherapy 10 mg) or dual antiplatelet therapy (aspirin 75-100 mg daily plus clopidogrel 75 mg daily for 3 months followed by aspirin monotherapy 75-100 mg). The primary efficacy outcome of interest was death or TE events, and the primary safety outcome was major bleeding events. After a median follow-up of 17 months, researchers found that there were significantly greater deaths or major TE events in the rivaroxaban group (HR 1.35, 95% confidence ratio 1.01 to 1.81, p=0.04) compared to the antiplatelet group. Deaths from any cause were also higher in the anticoagulant group (HR 1.69, 95% CI 1.13 to 2.53) when compared to the antiplatelet group. Based on an intention to treat analysis there were also a greater number of major, disabling, or life-threatening bleeding events in the anticoagulant group (HR, 1.50, 95% CI 0.95 to 2.37, p=0.08), though these results did not reach statistical significance. Overall, the results of this study do not support anticoagulant therapy with rivaroxaban 10 mg daily as a noninferior alternative to the currently recommended dual antiplatelet therapy post TAVR, given its increased risk of both TE events and bleeding related complications.

Click to read the study in NEJM

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aortic stenosisdual anti-platelet therapy (DAPT)rivaroxabanTranscatheter aortic valve replacement (TAVR)
Previous Post

Instantaneous reproduction number key in determining ability to relax COVID-19 restrictions

Next Post

Childhood obesity linked to increased early adulthood mortality

RelatedReports

#VisualAbstract: Transcatheter aortic valve implantation is associated with reduced rate of structural valve deterioration compared to surgery
StudyGraphics

#VisualAbstract: Transcatheter aortic valve implantation is associated with reduced rate of structural valve deterioration compared to surgery

December 20, 2022
Blood type correlates with egg reserve in infertile women
Cardiology

Apixaban is associated with a lower risk of gastrointestinal bleeding than other direct oral anticoagulants

November 17, 2022
Quick Take: Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse
Cardiology

Apixaban is superior to rivaroxaban in patients with atrial fibrillation and valvular heart disease

October 31, 2022
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Cardiology

Cerebral embolic protection during transcatheter aortic-valve replacement does not reduce the incidence of stroke

October 10, 2022
Next Post
Positive parenting intervention may decrease child socioemotional problems

Childhood obesity linked to increased early adulthood mortality

E-cigarette users have greater odds of subsequent cigarette use

Stores often sell tobacco to minors after checking identification

Children’s hospital visits for suicide ideation and attempts are increasing

Nature and nurture play disease specific roles in psychiatric illness across generations

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options